- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
February 25, 2020
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.
February 24, 2020
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer.
February 24, 2020
A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma.
February 24, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach.
February 21, 2020
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
February 21, 2020
Comparative outcomes of radio frequency ablation versus partial nephrectomy for T1 renal tumors: a systematic review.
February 20, 2020
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
February 19, 2020
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells.
February 19, 2020
Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma.
February 19, 2020
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.
February 18, 2020
Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
February 17, 2020
Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma.
February 17, 2020